Barth, Shannon K. http://orcid.org/0000-0002-4401-8371
Saulters, Kacie J.
Balba, Gayle P.
Monroe, Anne K.
Horberg, Michael A.
Kumar, Princy N.
Greenberg, Alan E.
Castel, Amanda D.
,
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (R24AI152598)
Article History
Accepted: 21 September 2023
First Online: 24 October 2023
Declarations
:
: Dr Barth: none; Dr Saulters: Alliance for Academic Internal Medicine, American College of Physicians 2021–2022, Paid to institution; Magnolia Regional Medical Center, Corinth MS 2020 and 2021, payment made to individual; Support for travel to Alliance for Academic Internal Medicine 2022, payment made to individual; Dr. Balba: Gilead, GlaxoSmithKline personal stocks; Dr. Kumar: Consulting fees from ViiV/GSK, Merck, Thera Technology, Johnson and Johnson, paid to individual; personal stocks in Pfizer, Gilead, Merck, Moderna, Johnson and Johnson; Dr. Greenberg: Invited speaker, Davidson College, paid to individual; DSMB/AB UW CFAR EAB (all unrelated), JHU CFAR EAB, ERC CFAR EAB, paid to individual; Dr. Castel: Research award from Gilead Sciences, Funding from National Institutes of Health, paid to individual; NIH NIDA Clinical Trials Network; personal stocks in Pfizer, Viatris, Inc.; Receipt of medications through Gilead Sciences grant as mentioned above, paid to institution.
: The survey was approved by the George Washington University Institutional Review Board (IRB) and specific sites’ IRBs (Washington DC Department of Veterans Affairs, Washington Hospital Center, Children’s National Medical Center).
: Electronic informed consent was obtained from all participants.